Food and Drug Administration

FDA to Ease Rules for New Alzheimer’s Drugs

Posted on 03/15/2013 by | Personal Health and Well-being | Comments

Bulletin Today | Personal HealthSaying there’s “a desperate need” for new Alzheimer’s treatments, the U.S. Food and Drug Administration (FDA) announced that it plans to ease the approval rules for experimental drugs in the hopes of slowing or preventing the devastating brain disease in its early stages. Noting that without new medications the number of Americans with Alzheimer’s could nearly triple to 16 million by 2050, the FDA’s Russell Katz, M.D., wrote on the agency’s blog that “it was with a sense of urgency” …

FDA Requires Lower Doses for Sleep Medications

Posted on 01/11/2013 by | General News | Comments

UncategorizedBy Matthew Perrone of The Associated Press WASHINGTON (AP) — The Food and Drug Administration is requiring makers of Ambien and similar sleeping pills to lower the dosage of their drugs, based on studies suggesting patients face a higher risk of injury due to morning drowsiness. The agency said Thursday that new research shows that the drugs remain in the bloodstream at levels high enough to interfere with alertness and coordination, which increases the risk of car accidents. Regulators are …

Ranbaxy Recalls Generic Lipitor Doses

Posted on 11/26/2012 by | General News | Comments

Bulletin Today | Personal HealthBy Linda A. Johnson, Business Writer, The Associated Press TRENTON, N.J. (AP) — Ranbaxy Pharmaceuticals Inc. has recalled dozens of lots of its generic version of cholesterol drug Lipitor because some may contain tiny glass particles, the latest in a string of manufacturing deficiencies that once led U.S. regulators to bar imports of the Indian company’s medicines. Ranbaxy, a subsidiary of Ranbaxy Laboratories Ltd., India’s biggest drugmaker, is operating under increased scrutiny from the U.S. Food and Drug Administration because …

Drug-Research Scandal: Patients Lose Again

Posted on 11/26/2012 by | Personal Health and Well-being | Comments

Bulletin Today | Personal HealthIsn’t anyone looking out for patients’ welfare these days? Last week we read about how the U.S. Food and Drug Administration was hampered from investigating problems at the compounding pharmacy accused of supplying tainted drugs linked to the recent meningitis outbreak that sickened nearly 500 and killed 34. Then on Sunday a Washington Post investigation charged that the drug industry’s growing influence over research on new medications has resulted in studies being manipulated to obscure dangerous side effects so the …

First Weekly Diabetes Drug Wins FDA Approval

Posted on 02/28/2012 by | Personal Health and Well-being | Comments

Bulletin Today | Personal HealthWell, now we know why celebrity chef Paula Deen was recently hired to promote the daily diabetes drug she takes: That drug is getting some new competition from Bydureon, the first once-a-week treatment for Type 2 diabetes approved by the U.S. Food and Drug Administration. The FDA approved the injectable, extended-release drug last month after several delays due to government concerns that it might cause heart rhythm abnormalities. Manufacturer Amylin Pharmaceuticals expects the drug to be available in pharmacies this …

Juicy News: Citrus May Cut Stroke Risk, But Beware of Grapefruit

Posted on 02/27/2012 by | Personal Health and Well-being | Comments

Bulletin Today | Personal HealthLots of citrusy health news recently: Researchers say a nutrient in vitamin C-rich fruits like oranges, tangerines and grapefruit may help lower women’s risk of stroke, but beware — the Food and Drug Administration also just issued a reminder that fresh grapefruit and grapefruit juice can interfere with some prescription and nonprescription drugs. According to a new study published last week in Stroke: Journal of the American Heart Association, women who ate the most citrus fruit had a 19 percent …

« Older Entries